About our founder
Makers of change. Investors in humanity.
Dr. Wayne Holman, the CEO and Founder of Ridgeback Capital, is a licensed physician and graduate of New York University School of Medicine with an undergraduate degree in economics from Yale University. Additionally, he is the co-founder of Ridgeback Biotherapeutics and serves as Co-Chair of the Ridgeback-Merck Molnupiravir Joint Steering Committee. He also serves as a member of the NYU Langone Board of Trustees. With a track record spanning over two decades, Dr. Holman has contributed funding to over 100 public and private biopharma companies, supporting the research and development of transformative medicines to address unmet needs. Residing in Miami, he shares his home with his wife, four children, and three dogs.
Ridgeback Capital was founded in 2006 and is focused on healthcare investments. Ridgeback invests in private and public companies that are dedicated to the development of life saving and life changing therapies. Healthcare advances take many years to materialize and Dr. Wayne Holman believes that patient capital is vital for new technologies and companies to thrive.
Our Namesake
Ridgeback Capital is named after our founder’s Rhodesian Ridgeback Coco. Coco was rescued from an animal shelter. For, over a decade, she happily thrived and was proud to be the namesake of Ridgeback Capital. Somewhat analogous to building a great company, Coco’s story is an excellent reminder that all good outcomes require thoughtful people who make great decisions.